This company listing is no longer active
Resumen de acción 9GM0
G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in the United States, China, and Israel.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Competidores de G Medical Innovations Holdings Ltd
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.50 |
| 52 Week High | US$47.60 |
| 52 Week Low | US$0.14 |
| Beta | -1.01 |
| 1 Month Change | -70.69% |
| 3 Month Change | -89.27% |
| 1 Year Change | -98.76% |
| 3 Year Change | -69.67% |
| 5 Year Change | -98.41% |
| Change since IPO | -99.01% |
Noticias y actualizaciones recientes
Recent updates
Rentabilidad de los accionistas
| 9GM0 | DE Healthcare | Mercado DE | |
|---|---|---|---|
| 7D | -70.7% | 0.3% | -1.4% |
| 1Y | -98.8% | 2.1% | 2.2% |
Rentabilidad vs. Industria: 9GM0 underperformed the German Healthcare industry which returned -28.3% over the past year.
Rentabilidad vs. Mercado: 9GM0 underperformed the German Market which returned -9% over the past year.
Volatilidad de los precios
| 9GM0 volatility | |
|---|---|
| 9GM0 Average Weekly Movement | 46.4% |
| Healthcare Industry Average Movement | 6.2% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.2% |
| 10% least volatile stocks in DE Market | 2.5% |
Precio estable de las acciones: 9GM0's share price has been volatile over the past 3 months.
Volatilidad a lo largo del tiempo: 9GM0's weekly volatility has decreased from 357% to 46% over the past year, but is still higher than 75% of German stocks.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 2014 | n/a | Yacov Geva | gmedinnovations.com |
Resumen de fundamentos de G Medical Innovations Holdings Ltd
| Estadísticas fundamentales de 9GM0 | |
|---|---|
| Capitalización bursátil | €3.87m |
| Beneficios(TTM) | -€21.17m |
| Ingresos (TTM) | €3.99m |
1.0x
Ratio precio-ventas (PS)-0.2x
Ratio precio-beneficio (PE)¿Está 9GM0 sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de 9GM0 | |
|---|---|
| Ingresos | US$4.36m |
| Coste de los ingresos | US$8.91m |
| Beneficio bruto | -US$4.56m |
| Otros gastos | US$18.53m |
| Beneficios | -US$23.08m |
Últimos beneficios comunicados
Jun 30, 2022
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | -3.11 |
| Margen bruto | -104.57% |
| Margen de beneficio neto | -529.84% |
| Ratio deuda/patrimonio | -71.9% |
¿Cómo se ha desempeñado 9GM0 a largo plazo?
Ver rendimiento histórico y comparativa